For a skin boil or abscess, which is more appropriate: cloxacillin or co‑amoxiclav (amoxicillin + clavulanic acid)?

Cloxacillin or Co-amoxiclav for Skin Boils or Abscess

For uncomplicated skin boils and abscesses, incision and drainage is the primary treatment, and when antibiotics are indicated, cloxacillin (or other penicillinase-resistant penicillins) is the preferred choice over co-amoxiclav for typical community-acquired cases.

Treatment Algorithm

Step 1: Determine if Antibiotics Are Even Needed

The 2014 IDSA guidelines are explicit: incision and drainage alone is the recommended treatment for furuncles, carbuncles, and abscesses 1. Antibiotics should only be added based on specific criteria:

• Systemic signs of infection (SIRS): Temperature >38°C or <36°C, heart rate >90 bpm, respiratory rate >24/min, or WBC >12,000 or <4,000 cells/µL
• Markedly impaired host defenses (immunocompromised patients)
• Carbuncles (coalescent infections involving multiple follicles)
• Failed drainage alone

For simple furuncles without systemic symptoms, antibiotics are typically unnecessary 1.

Step 2: Choose the Right Antibiotic When Indicated

When antibiotics are warranted, the choice depends on the likely pathogen:

For typical community-acquired boils/abscesses (methicillin-susceptible S. aureus):

• Cloxacillin or other penicillinase-resistant penicillins are first-line 1
• First-generation cephalosporins are acceptable alternatives
• The guideline specifically states these agents are "usually effective as most staphylococcal isolates from impetigo and ecthyma are methicillin susceptible" 1

Co-amoxiclav is NOT the preferred agent for several reasons:

1. Spectrum mismatch: Co-amoxiclav provides unnecessarily broad coverage, including activity against anaerobes and some gram-negatives that are not typical pathogens in simple boils 1

2. Higher side effect burden: Co-amoxiclav has significantly higher gastrointestinal side effects (34% vs 3% compared to cephalosporins in one study) 2, primarily due to the clavulanic acid component 3, 4

3. Antimicrobial stewardship: Using narrower-spectrum agents like cloxacillin helps preserve broader-spectrum antibiotics and reduces selection pressure for resistance 5, 4

4. Equivalent efficacy: Recent data shows cloxacillin is non-inferior to co-amoxiclav for staphylococcal infections 5

Step 3: When Co-amoxiclav Might Be Considered

Co-amoxiclav may be appropriate in specific scenarios:

• Polymicrobial infections: When both S. aureus AND streptococci are suspected or confirmed 1
• Complicated skin infections: Cellulitis with systemic involvement where broader coverage is needed 6
• Penicillin allergy: Though in this case, alternatives like clindamycin or doxycycline are preferred over co-amoxiclav 1
• MRSA concern: Though neither agent is appropriate; TMP-SMX, doxycycline, or clindamycin should be used 1

Common Pitfalls to Avoid

1. Over-prescribing antibiotics: Most simple boils need only drainage 1
2. Using co-amoxiclav as default: This promotes resistance and causes more side effects without added benefit for typical cases
3. Skipping culture: For carbuncles and abscesses, culture is recommended to guide therapy, though treatment without culture is reasonable in typical cases 1
4. Inadequate drainage: Antibiotics cannot substitute for proper surgical drainage 1

Practical Dosing Considerations

• Cloxacillin: Standard adult dosing is 500 mg four times daily for 5-10 days
• Co-amoxiclav: If used, the clavulanic acid component is limited to 125 mg per dose due to tolerability 7, 4, which may limit achievable amoxicillin doses

The evidence strongly supports a narrow-spectrum, targeted approach with cloxacillin for typical skin boils and abscesses when antibiotics are indicated, reserving co-amoxiclav for more complex or polymicrobial infections.